Clinical trial
Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)
NCT07921719 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- January 31, 2030
- Enrollment
- 5,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer screening, smoking cessation
Arms
As registered; 2 arms.
-
PROMETHEE Cohort
Participants enrolled in IMPULSION and referred to the PROMETHEE tele-tobacco platform. The pathway includes facilitated access to smoking cessation specialists, up to four follow-up teleconsultations, and systematic consideration of pharmacological cessation treatment.
-
Control Cohort
Matched IMPULSION participants receiving standard smoking cessation support according to local resources and the routine IMPULSION program
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Self-reported Smoking Cessation at 12 Months
Proportion of participants reporting smoking cessation 12 months after inclusion through the IMPULSION electronic follow-up questionnaire.
Lead sponsor's other trials
Hospices Civils de Lyon, most recent start first.
+1,861 more trials See the organization page